Hyperfine appoints Rob Fasciano, PhD, and Rafael O’Halloran, PhD, to help advance AI-powered MRI technology and scale next-gen imaging solutions.

Hyperfine, Inc. Reports First Quarter 2025 Financial Results. GUILFORD, Conn., May 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that ...

Hyperfine (HYPR) announced FDA clearance that includes an entirely new portable MRI scanner powered by the proprietary Optive AI software. The ...

Hyperfine, Inc. (NASDAQ: HYPR), the company behind the world’s first FDA-cleared portable MRI system powered by artificial intelligence – the Swoop® system – has received FDA approval for ...

This clearance is the most significant innovation in the history of Hyperfine. We plan to launch the new Swoop® system across hospital and office settings in the US, and we believe the new Swoop ...

Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop® system—the first FDA-cleared, AI-powered, portable, ultra-low ...

Hyperfine (Nasdaq:HYPR) announced today that the FDA cleared its latest portable MRI scanner powered by proprietary AI software. The Guilford, Connecticut-based company says the clearance marks a ...

A detailed quantum chemical analysis of the underlying principles of hyperfine coupling in 3d transition metal complexes has been carried out. The explicit evaluation of one- and two-electron ...

Get the latest news on Hyperfine stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Hyperfine performance ...